Delivery Order 36F79719D0108-36C24924F0169
Award Date
8/2/24
Potential Completion Date
8/12/24
Potential Value
$63K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Amicus Therapeutics US, LLC
Ultimate Awardee
Amicus Therapeutics, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The order, valued at $21,089.47, is for the pharmaceutical product Galafold 123 mg, an enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder. The order is a firm fixed-price contract with no set-aside designation. Amicus Therapeutics US, LLC holds a Pharmaceuticals and Drugs Federal Supply Schedule contract...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the supply of 3 bottles of Galafold, an enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder. The contract, valued at $65,673.63, is part of a larger Federal Supply Schedule (FSS) contract (36F79724D0185) between the VA and Amicus Therapeutics US, LLC, which is valid through...
The U.S. Department of Veterans Affairs (VA) awarded a $21,089.47 firm fixed price delivery order contract to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the supply of GALAFOLD 123 MG, an enzyme replacement therapy for the treatment of Fabry disease. This delivery order was placed under Amicus Therapeutics US, LLC's Federal Supply Schedule (FSS) contract 36F79724D0185, which has a ceiling value of $13,024,630 and a period of performance through...
This is a $21,089.47 firm fixed price delivery order issued by the Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the pharmaceutical product Galafold 123 mg, an FDA-approved enzyme replacement therapy used to treat Fabry disease. This delivery order is placed against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) with the General Services Administration. The...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is a $21,089.47 firm fixed price delivery order for the supply of Galafold (migalastat), an FDA-approved enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder. The contract has an ultimate completion date of October 7, 2024 and was awarded on October 3, 2024. The contract is not set aside and Amicus...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a $60,374.73 delivery order to Amicus Therapeutics US, LLC under the company's Pharmaceuticals and Drugs Federal Supply Schedule contract. The one-month order is for an emergency purchase of Galifold, a medication used to treat adult patients with a rare disease called Fabry disease. As the lead agency serving veterans, the VA aims to ensure former military personnel and their families...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., for the specialty medication Galafold (migalastat) to treat Fabry disease. The $21,089.47 award was placed against Amicus Therapeutics, Inc.'s Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract with the General Services Administration, which provides a mechanism for federal agencies to procure...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the emergency procurement of migalastat (Galafold), a drug used to treat Fabry disease, a rare genetic disorder. The delivery order, valued at $21,089.47, was placed against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract administered by the General...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order to Amicus Therapeutics US, LLC, a subsidiary of publicly traded biopharmaceutical company Amicus Therapeutics, Inc. The order, valued at $21,089.47, is for the specialty medication Galafold (migalastat) to treat Fabry disease. The delivery order was placed against Amicus Therapeutics US, LLC's five-year Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), a...
This is a Firm Fixed Price Delivery Order awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The $21,089.47 contract is to provide the pharmaceutical product Galafold (migalastat) to the VA. The contract is placed against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract administered by the General Services Administration. No set-aside designation is applied to the...